Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Oberg

Showing results (161-170 of 302) with videos related to

Pageof 31
Sort By:
Cancer Research|June 1, 1990
Effects of interferon on tumor tissue content in liver metastases of human carcinoid tumorsT Andersson, E Wilander, B Eriksson, et al.
The Biochemical Journal|November 15, 1987
Characterization of three peptides derived from prosomatostatin [prosomatostatin-(1-63)-, -(65-76)- and -(79-92)-peptides] in a human pancreatic tumourJ M Conlon, B Eriksson, L Grimelius, et al.
Cancer Research|June 11, 1998
Determination of somatostatin receptor subtype 2 in carcinoid tumors by immunohistochemical investigation with somatostatin receptor subtype 2 antibodiesE T Janson, M Stridsberg, A Gobl, et al.
Acta Oncologica (Stockholm, Sweden)|June 25, 1999
In vivo cellular distribution and endocytosis of the somatostatin receptor-ligand complexA Lukinius, U Ohrvall, J E Westlin, et al.
Acta Oncologica (Stockholm, Sweden)|February 28, 2002
Health-related quality of life, anxiety and depression in patients with midgut carcinoid tumoursG Larsson, P O Sjödén, K Oberg, et al.
Akusherstvo I Ginekologiia|February 1, 1988
[State of the cholinergic system in the first stage of labor during nonpharmacologic analgesia]S M Zol'nikov, O K Oberg, L B Krasnova, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|August 10, 2000
Use of PET in neuroendocrine tumors. In vivo applications and in vitro studiesB Eriksson, M Bergström, H Orlefors, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 20, 2000
Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumorsE T Janson, J E Westlin, U Ohrvall, et al.
Anticancer Research|March 1, 1994
Ki-67 immunostaining and DNA flow cytometry as prognostic factors in epithelial ovarian cancersR Henriksen, P Strang, T Backstrom, et al.
Regulatory Peptides|January 26, 1995
Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumoursM Stridsberg, B Eriksson, G Lundqvist, et al.
Pageof 31

Showing results (161-170 of 302) with videos related to

Sort By:
Pageof 31
Cancer Research|June 1, 1990
Effects of interferon on tumor tissue content in liver metastases of human carcinoid tumorsT Andersson, E Wilander, B Eriksson, et al.
The Biochemical Journal|November 15, 1987
Characterization of three peptides derived from prosomatostatin [prosomatostatin-(1-63)-, -(65-76)- and -(79-92)-peptides] in a human pancreatic tumourJ M Conlon, B Eriksson, L Grimelius, et al.
Cancer Research|June 11, 1998
Determination of somatostatin receptor subtype 2 in carcinoid tumors by immunohistochemical investigation with somatostatin receptor subtype 2 antibodiesE T Janson, M Stridsberg, A Gobl, et al.
Acta Oncologica (Stockholm, Sweden)|June 25, 1999
In vivo cellular distribution and endocytosis of the somatostatin receptor-ligand complexA Lukinius, U Ohrvall, J E Westlin, et al.
Acta Oncologica (Stockholm, Sweden)|February 28, 2002
Health-related quality of life, anxiety and depression in patients with midgut carcinoid tumoursG Larsson, P O Sjödén, K Oberg, et al.
Akusherstvo I Ginekologiia|February 1, 1988
[State of the cholinergic system in the first stage of labor during nonpharmacologic analgesia]S M Zol'nikov, O K Oberg, L B Krasnova, et al.
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|August 10, 2000
Use of PET in neuroendocrine tumors. In vivo applications and in vitro studiesB Eriksson, M Bergström, H Orlefors, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|September 20, 2000
Nuclear localization of 111In after intravenous injection of [111In-DTPA-D-Phe1]-octreotide in patients with neuroendocrine tumorsE T Janson, J E Westlin, U Ohrvall, et al.
Anticancer Research|March 1, 1994
Ki-67 immunostaining and DNA flow cytometry as prognostic factors in epithelial ovarian cancersR Henriksen, P Strang, T Backstrom, et al.
Regulatory Peptides|January 26, 1995
Islet amyloid polypeptide (IAPP) in patients with neuroendocrine tumoursM Stridsberg, B Eriksson, G Lundqvist, et al.
Pageof 31